Skip to main content
SpringerLink
Log in

Trastuzumab/trastuzumab-emtansine

Acquired drug resistance

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chui MH, et al. Decreased HER2 expression in endometrial cancer following anti-HER2 therapy. Journal of Pathology 262: 129-136, No. 2, Feb 2024. Available from: URL: https://dx.doi.org/10.1002/path.6230

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trastuzumab/trastuzumab-emtansine. Reactions Weekly 2008, 347 (2024). https://doi.org/10.1007/s40278-024-59241-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-59241-4

Search

Navigation